DATE: October 25, 2017
TIME: 08:00am PDT, 11:00am EDT

As we learn more about the implications of genetic variation in 21st century medicine, the utilization of genotyping as a molecular tool both in the research and clinical setting is as important and popular as ever. This presentation will exemplify the power and precision of the Applied Biosystems™ Axiom™ genotyping platform in several settings. Examples will include the use of Applied Biosystems™ Axiom™ Genotyping Arrays in the Department of Veterans Affairs’ Million Veteran Program (MVP), the use of the Applied Biosystems™ Axiom™ Precision Medicine Research Array, the use of the Applied Biosystems™ PharmacoScan Solution for pharmacogenetics, as well as using a unique custom array for potential dementia risk assessment. The talk will be presented from the perspective of a global service provider.

In this webinar, Dr. Mark Bouzyk will:

• Demonstrate the flexibility and accuracy of the Axiom Genotyping platform and how it is particularly suitable for large-scale genomic studies
• Explain how the recently developed Axiom Precision Medicine Research Array can be used in a wide variety of disease and therapeutic research areas
• Discuss new arrays including the PharmacoScan Solution for pharmacogenomics research and a custom Axiom array for dementia, particularly Alzheimer’s disease, and the usefulness of these arrays in clinical research trials for stratifying populations

For Research Use Only. Not for use in diagnostic procedures.